MRNS - Marinus Pharmaceuticals Inc Qarzning balans kapitallashuviga nisbati
Qarzning bozor kapitalizatsiyasiga nisbati grafigi Marinus Pharmaceuticals (MRNS) kompaniyasi epilepsiyaning kam uchraydigan turlari uchun dori vositalari savdosiga qanchalik tayanishini ko'rsatadi, bu esa bashorat qilinadigan daromadni kafolatlaydi. Biroq, yangi dori vositalarining noaniq sinovlari himoya to'sig'iga bosim o'tkazmoqda va ko'rsatkich qiymati 0.00 darajasida turibdi. Moddalar ishlab chiqarishning to'liq autsorsing qilinishi kritik zaiflikni yuzaga keltirib, biznesni uchinchi tomon imkoniyatlarining asiriga aylantirmoqda.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_MRNS_-_Marinus-Pharmaceuticals_-_Debt-to-Net-Assets-Ratio "Marinus Pharmaceuticals, Inc. - MRNS Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 22.02.2025) | 👁️GURU.Markets👁️")
Marinus Pharmaceuticals Inc (MRNS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Marinus Pharmaceuticals|MRNS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Marinus|MRNS - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Marinus Pharma|MRNS - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi Marinus Pharmaceuticals
Kompaniyaning fundamental tahlili:Marinus Pharmaceuticals
Bozor kutuvlari ko'pincha emitentning haqiqiy moliyaviy barqarorligidan farq qiladi. Kredit kapitalining kompaniyaning kitob kapitalizatsiyasiga nisbatan dinamikasi umumiy majburiyatlarning sof aktivlar qiymatiga nisbatini ko'rsatadi. Ushbu koeffitsiyentning oshishi defolt xatarlarining yuqoriligidan dalolat beradi. Marinus Pharmaceuticals (MRNS) uchun ushbu balans xodimlarni optimallashtirish va R&D jarayonlarini yangilashda hal qiluvchi ahamiyatga ega. Ushbu metrikaning barqarorligi kompaniyaning haddan tashqari kredit bosimi bo'lmagan holda asosiy Ztalmy neyrobiologlarini saqlab qolish qobiliyatini tasdiqlaydi.
Marinus Pharmaceuticals kimlar bilan raqobatlashadi
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|XENE (Xenon Corp) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati VKTX|Qarzning balans qiymatiga nisbati supernus.com|Balans kapitallashuviga qarzlar CPRX|Balans kapitallashuviga qarzlar DNLI (Denali)|Qarzning balans kapitallashuviga nisbati Harmony Pharma|Qarzning sof aktivlarga nisbati Biohaven Corp BHVN|Balans kapitallashuviga qarzlar AMLX (Amylyx Pharmaceuticals)|TRVI: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Praxis Precision Medicines, Inc.|Qarzning balans qiymatiga nisbati Anavex|CBLL (CeriBell Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PRTA|ALEC (Alector, Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar annexonbio.com ANNX|Qarzning balans qiymatiga nisbati Omeros|Neurogene Inc - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati AC Immune Corp|VYGR - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Neumora Therapeutics NMRA|scilexholding.com (SCLX) - Qarzning sof aktivlarga nisbati|TVGN (Tevogen Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ACOG|Cognition Therapeutics (CGTX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati IKT (Inhibikase Pharma)|Cassava Sciences, Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Assertio Holdings ASRT|Coya - Balans kapitallashuviga qarzlar|VTGN - Balans kapitallashuviga qarzlar|OVID (ovidrx.com) - Balans kapitallashuviga qarzlar|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CRVO (CervoMed Inc.)|Balans qiymatiga qarzlar Alterity Therapeutics Ltd (ATHE)|Qarzning balans qiymatiga nisbati CLNN|Balans kapitallashuviga qarzlar pepgen.com PEPG|Qarzning balans qiymatiga nisbati Jupiter Neurosciences Inc (JUNS)|Qarzning balans kapitaliga nisbati Relmada Corp RLMD|Balans kapitallashuviga qarzlar ANVS (Annovis Bio, Inc.)|GRCE - Sof aktivlarga qarzlar|AIFF (Firefly Neuroscience) - Balans kapitallashuviga qarzlar|Klotho Neurosciences (KLTO) - Qarzning balans qiymatiga nisbati|NRSN (NeuroSense Therapeutics Ltd) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar RVPH|Qarzning balans kapitallashuviga nisbati MetaVia Inc (MTVA)|Qarzning balans kapitallashuviga nisbati NRXS (neuraxis.com)|Qarzning balans kapitallashuviga nisbati HSDT|Passage Bio Inc. - Sof aktivlarga qarzlar|NEUP: Qarzning balans kapitallashuviga nisbati|NERV: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Athira Pharma, Inc. ATHA|ADXN (addextherapeutics.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Alzamend Neuro Inc. (ALZN)|Qarzning balans qiymatiga nisbati CYCN|PTIX (Protagenic Therapeutics) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar KTTA (pasitheaclinics.com)|CRGT - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati avenuetx.com ATXI|BCLI (BrainStorm Cell Therapeutics) - Balans kapitallashuviga qarzlar|Cara Therapeutics Inc. (CARA) - Balans qiymatiga qarzlar|CHRO: Qarzning balans qiymatiga nisbati|ELYM (Eliem Therapeutics Inc.) - Balans kapitallashuviga qarzlar|ITCI - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati LBPH|NKGen Biotech - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar NRBO (NeuroBo Pharmaceuticals Inc)|Sage Therapeutics, Inc - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Synaptogenix, Inc SNPX|Trevena, Inc. - Balans kapitallashuviga qarzlar|VIGL: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Anew Medical WENA|Cerevel Therapeutics Inc (CERE) - Qarzning sof aktivlarga nisbati